Clinical Trial Update: Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. [Phase 3]

View source ↗

Summary

Phase 3 safety study evaluating a vaccine against meningitis in infants following a birth dose of hepatitis B; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type
• Hepatitis B
• Tetanus
• Whole Cell Pertussis

Drugs mentioned

• GlaxoSmithKline (GSK) meningitis vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Diphtheria | Phase 3 | Status: COMPLETED